Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. - Wikidata - awgldk - TriplyDB

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.

http://www.wikidata.org/entity/Q44425588

about

Targeted DNA mutagenesis for the cure of chronic viral infections HBV induced HCC: major risk factors from genetic to molecular level Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach Hepatitis B virus molecular biology and pathogenesis The Role of cccDNA in HBV Maintenance.Detection of HBV Covalently Closed Circular DNA Hepatitis B virus replication induces methylation of both host and viral DNA.Occult HBV infection: a faceless enemy in liver cancer development.Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact Current status of antiviral therapy for hepatitis B Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR.Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection.Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus.HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients.Detection of Hepatitis B Virus Covalently Closed Circular DNA in the Plasma of Iranian HBeAg-Negative Patients With Chronic Hepatitis B.Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway.Molecular testing in the diagnosis and management of chronic hepatitis B Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.Virus and Host Testing to Manage Chronic Hepatitis B.Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.Hepatitis B virus infection and transfusion medicine: science and the occult.Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B Quantification of pregenomic RNA and covalently closed circular DNA in hepatitis B virus-related hepatocellular carcinoma.Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.How to achieve immune control in chronic hepatitis B?Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells.Requirement of CRTC1 coactivator for hepatitis B virus transcription Key elements of the RNAi pathway are regulated by hepatitis B virus replication and HBx acts as a viral suppressor of RNA silencing.

P2860

Q24620150-7C038B66-2DAF-4AA8-8A2D-9A095D6E1833 Q26825274-04289F65-D182-454C-B1D5-B1626CF2EB58 Q27324340-3BEC2619-E359-43EC-A3FA-4F62BCF68D77 Q28818406-10CE90E9-E868-424F-9D63-32393B66471B Q32182914-42F881AF-884B-4638-BEBE-A32C1AB3AD6F Q32183310-06899E27-3721-436A-92DF-78DBCDF2B408 Q33530611-BAD03C7A-0DA1-40ED-9918-09534C844227 Q33584773-1B3BDB12-BF82-40F4-A4CE-338DD9696596 Q33695646-01180338-A594-4E11-8C8C-D533D07704DA Q34289969-90A105BB-FCB5-45B6-AFD6-BDB03D562C6D Q34387363-B4E9B195-6222-446F-A897-99C9282F9245 Q34408879-8E9ACF2B-744C-4B34-A986-24AC24D14EF4 Q34457758-6586E663-9995-4D67-8512-E5F6580B3AB9 Q34685945-9600ACDC-784A-4FA0-8B1D-1093FE0E28BA Q34998226-3B94D8F7-1026-47B2-8BC8-AC01E80B9F0D Q35097179-20FB625D-FD4E-433A-8BBD-CFDF002414A2 Q35097694-2DF9025E-4491-49E6-AC6F-F36906B539E1 Q35473087-F03DEE3C-9480-4E94-A563-3261C39874C8 Q35531299-D7FB02B9-7733-4947-84A9-4B335764EAF3 Q35706571-CA9013DF-A7F0-4439-B843-224C79A33305 Q36182533-BBA50258-9690-4C12-8375-7DA002B6ADD7 Q36358166-3E517A0A-E996-43CC-88BD-8F644C647716 Q36730743-21F8CFD1-1C93-4691-B282-1D656765CA04 Q36819538-6999C642-4376-4B85-9015-862F3AB0A2B0 Q36881140-39C7C792-6A55-479A-AC79-BF52534C66F8 Q36951290-FCA8139B-BAA8-4AF3-982B-91B24C599863 Q36958940-763A44D9-AA87-406B-987F-AAB2C9E291FD Q37074608-075ED54F-1C1C-4FC1-98E7-F8B000C2CF21 Q37153782-EC892852-7422-4B27-9331-AD0BC5A5AEBE Q37254885-09300AAA-4083-4848-B24E-E25AEB7C48E1 Q37380078-7B2DE7C7-38E2-47E3-B56E-CA17B07889A3 Q37433006-C5220455-48F5-4BD0-A09C-8FDF5090A348 Q38377562-385E5FE1-AB63-445B-9BE8-B472984C8A4A Q38383489-0B0C2CFB-828E-4A63-B161-2A8770DE7819 Q38566445-2FE95029-54A3-4C1F-B2B7-F8E841327C6E Q38736225-851668BF-238B-46C4-A95D-CCC23CEA92AB Q38837061-04C815DB-8247-4377-93A2-3AEDD7F90D52 Q38891568-BF47F69B-C19D-49A3-B761-8C6DD7845273 Q38949360-F4100710-8DA0-4368-9FB8-51F16F0C3ACA Q38987882-452CC23F-C69A-4C1E-AAAA-29FCACFFCE5D

P2860

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.

http://www.wikidata.org/entity/Q44425588

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Intrahepatic levels and replic ...... chronically infected patients.

@en

Intrahepatic levels and replic ...... chronically infected patients.

@nl

type

label

Intrahepatic levels and replic ...... chronically infected patients.

@en

Intrahepatic levels and replic ...... chronically infected patients.

@nl

prefLabel

Intrahepatic levels and replic ...... chronically infected patients.

@en

Intrahepatic levels and replic ...... chronically infected patients.

@nl

P1433

Q44425588-26D4E2A0-B515-4CCF-B320-207D8597BA94

P1476

Q44425588-845A7635-6CB4-4B38-AE9A-55114D2C4AF7

P2093

Q44425588-38D87B17-73AA-4F0A-948A-B9B685A7EDED

Q44425588-442C3CBA-59E7-4C65-87C6-FC2DE7A3B498

Q44425588-4F92D42C-5F32-441F-AE68-CD2EBCB90859

Q44425588-6980AC34-232F-4D6B-AABD-15116D6CBD42

Q44425588-E22B7621-311C-411B-9F60-0F54CD8A9492

P2860

Q44425588-3576673A-5C5F-4F3D-8693-346279007574

P304

Q44425588-1F4D9A20-FED4-4E56-887D-00B3E25E1A91

P31

Q44425588-D33F86B9-12DA-4B8A-9DE3-2ABDE8F42280

P356

Q44425588-0A0A0A9C-3972-41EB-9AB1-AACA43258829

P407

Q44425588-A5E7C193-C699-4821-8AB6-B4811B3BD0CA

P433

Q44425588-8F5ABBF7-BF75-45AA-9DE7-8040DFA459D1

P478

Q44425588-D88DC9A0-AE81-46CA-8C7A-A619A3D951EF

P577

Q44425588-76C624DE-CA28-4D28-9EC7-841FA7CEBB9C

P5875

Q44425588-BD819059-88C7-4AF0-B0FE-E90B9EAD8232

P698

Q44425588-2293B60E-ACB5-4D96-81FC-EF0CAEC6F12A

P356

P1433

P1476

Intrahepatic levels and replic ...... chronically infected patients.

@en

P2093

Ageliki Kostamena

http://www.w3.org/2001/XMLSchema#string

Andreas Laras

http://www.w3.org/2001/XMLSchema#string

Evangelini Dimou

http://www.w3.org/2001/XMLSchema#string

John Koskinas

http://www.w3.org/2001/XMLSchema#string

Stephanos J Hadziyannis

http://www.w3.org/2001/XMLSchema#string

P2860

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter.

P304

694-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21299

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6846471

http://www.w3.org/2001/XMLSchema#string

P698

16941694

http://www.w3.org/2001/XMLSchema#string